Schnell Biopharmaceuticals Inc. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW37.53 |
Market Cap |
KRW250.34 B |
Shares Outstanding |
214.89 M |
Public Float |
80.6 M |
Address |
Room 301 Gangho Building Seoul SL 06735 Korea, Republic Of |
Employees | - |
Website | http://www.aprogen-pharm.com |
Updated | 07/08/2019 |
Aprogen Pharmaceuticals, Inc. engages in the manufacture and sale of pharmaceutical products. It operates throught the Pharmaceutical Manufacturing and Wholesale business divisions. The Pharmaceutical Manufacturing division provides antibiotics, antirhematics, and medicines for dermatopathy. |